SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-10-07
👔
Mirum Pharmaceuticals, Inc.
@MIRM_InsiderForm 4 Filing: Peetz Christopher Exercises Options for $211K of $MIRM
OPTION EXERCISE
⚡ MATERIALITY: 5/10
corporate issuer
Mirum Pharmaceuticals, Inc.
Ticker: $MIRM
Transaction Value
$211K
Price/Share: $17.31
transaction date
2026-10-06
Shares: 12,197
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Peetz Christopher, holds the title of CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc..
On 2026-10-06, the insider transacted 12,197 shares.The shares were transacted at a weighted average price of $17.31 per share, resulting in a total market-relevant value of $211K.
Executive Summary Summary
Peetz Christopher (CHIEF EXECUTIVE OFFICER) exercised options for $211K of $MIRM
Post-Transaction Position: 206,637 shares
SEC Accession No: 0001614740-26-000014 (CIK: 1614740)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.